Biotricity is trading at $0.05, up 11.86%, with no clear company-specific catalyst identified for the October 14 move. - Biotricity’s newsroom shows no announcement dated October 14, and available search results do not establish a direct reason for the gain. - Healthcare rose 1.64%, offering sector context but not establishing the cause of Biotricity’s larger move. - Major U.S. indexes are mixed, with none showing a same-direction move above 0.5%.